Tag
DCT cost analysis
-
How Inoc Stacks Up Against Medidata in Decentralized Trials: A Cost Breakdown
The misconception that Medidata’s brand guarantees lower total costs persists, but real-world data from mid-sized biotechs reveals that Inoc’s per-patient...